Baek-yeol Y. Ryoo
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 206 publications
Predicting Chemotherapy Response in Patients With Advanced or Metastatic Pancreatic Cancer Using Machine Learning.
Journal: JCO clinical cancer informatics
Published: December 02, 2025
Second-Line and Subsequent Therapies after Atezolizumab Plus Bevacizumab Treatment in Hepatocellular Carcinoma: A Multicenter Prospective Cohort Study.
Journal: Gut and liver
Published: October 29, 2025
Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma.
Journal: Annals of hepatology
Published: October 03, 2025
Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer: A Randomized Clinical Trial.
Journal: JAMA network open
Published: October 01, 2025
Modified FOLFIRINOX with or Without Stereotactic Body Radiation in Locally Advanced Unresectable Pancreatic Cancer (SABER): A Randomized Open-Label Phase 2 Trial.
Journal: Annals of surgical oncology
Published: September 16, 2025
Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study.
Journal: Journal of hepatocellular carcinoma
Published: June 19, 2025
A Phase II Trial of Pemetrexed Plus Oxaliplatin in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin-based Chemotherapy.
Journal: Anticancer research
Published: June 10, 2025
Bevacizumab plus Erlotinib in Advanced Solid Cancers with Krebs Cycle Gene Mutations: A Multicenter Phase II Study (BRISK; KCSG AL22-16).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2025
Multicenter single-arm phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab.
Journal: Journal of hepatology
Published: May 10, 2025
Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinoma.
Journal: Journal of hepatology
Published: January 22, 2025
Atezolizumab plus Bevacizumab Is Associated with Favorable Overall Survival over Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma.
Journal: Oncology
Published: December 12, 2024
Last Updated: 09/26/2026